Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B
NCT03938792
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
189
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemophilia A
Hemophilia B
Interventions
DRUG:
PF-06741086
Sponsor
Pfizer